Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / InSitu Biologics, Inc

InSitu Biologics, Inc

Stage unknownOakdale, MNBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Nov 13, 2025
    Form D equity offering · $4.0M (form d sold) · 29 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “InSitu Biologics, Inc filed Form D: $3,950,000 sold of $8,000,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
3 officers, 3 directors
Timeline
1
  1. Dec 18, 2025
    InSitu Biologics, Inc filed Form D: $3,950,000 sold of $8,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company